Sabeen Mekan
CIK: 0002106866
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZYME
Zymeworks Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Mekan Sabeen
Mekan Sabeen (SEC CIK 0002106866) files insider reports with the SEC as SVP & Chief Medical Officer of Zymeworks Inc. (ZYME).
Signal8 holds 1 ownership filing by Mekan Sabeen, a Form 3, filed on Feb 2, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Mekan Sabeen's filings is in MIDDLETOWN, DE.
Other insiders filing for Zymeworks Inc. (ZYME)
- Schayowitz Adam, EVP, Head of R&D
- Hollywood Mark, EVP & Chief Operating Officer
- Schneider Paul R, EVP, General Counsel
- Platshon Scott, EVP, Chief Business Officer
- Stafford Kristin, EVP, Chief Financial Officer
- Cherry Brian N, Director